Background To date, carbohydrate antigen 19− 9 (CA19-9) and carcinoembryonic antigen
(CEA) have been widely used for the screening, diagnosis and prediction of biliary tract …

Objective: To explore the diagnostic value of carbohydrate antigen 19-9 (CA 19-9) and
carcinoembryonic antigen (CEA) for the diagnosis of intrahepatic cholangiocarcinoma (ICC) …

Methods This cross-sectional study was conducted on 54 patients with typical radiological
criteria of HCC and elevated CA19-9 level. And were classified into two groups I included 22 …

Background and objectives: Cancer-associated carbohydrate antigen 50 (CA50) is a marker
for detection of gastrointestinal cancers, especially of pancreatic and colon cancer. In this …

Background Serum carcinoembryonic antigen (CEA) and carbohydrate antigen (CA) 19-9
have been proposed as useful preoperative biomarkers of extrahepatic bile duct cancer …

Purpose Although serum CEA and CA 19-9 have been widely utilized for the diagnosis of
gallbladder cancer (GBC), few studies have examined the diagnostic performance of them …

Background/Aim: The major limitation of carbohydrate antigen (CA) 19-9 as a tumor marker
is the high incidence of false-positive results during cholestasis. We evaluated preoperative …

Background Role of tumor markers in gall bladder carcinoma (GBC) is not well established.
We evaluated the prognostic value of carbohydrate antigen 19–9 (CA19–9) and carcinoma …

Page 2 of 3 Translational Gastroenterology and Hepatology, 2019 iCC (3). Surgical
resection is the only established curative treatment for iCC; however, recurrence occurs …

Objective To investigate the value of serum and biliary carcinoembryonic antigen (CEA),
carbohydrate antigen 19-9 (CA19-9), and carbohydrate antigen 24-2 (CA24-2) in the …